Skip to content
TirzepatideReport

Tirzepatide monograph · Evidence review

VirtualCare2Go Tirzepatide Review: Cost, Same-Day Visits & Honest Verdict (2026)

An honest 2026 review of VirtualCare2Go tirzepatide — same-day telehealth visits and national shipping, but a required video visit and above-median price.

Researched & written by Alan Pierce · last updated

Clinical Pharmacology Writer

On this page

Editorial pick

CoreAge Rx

$149/mo flat

Doctor-reviewed tirzepatide with one flat price and built-in human support.

Advertising disclosure · we may earn a commission at no extra cost to you.

Check availability
vs median
$120/mo below the $269 median
Market
$109–$429/mo across 396 providers
Dispensed
Compounded tirzepatide (503A)

Popular alternative

Sesame Care

Established national telehealth marketplace with the widest real brand-name access — Zepbound, Mounjaro, Wegovy, Ozempic, and oral Rybelsus — though brand meds carry a separate platform subscription.

Zepbound from $299/mo + $99/mo subscription

Check Sesame Care availability

VirtualCare2Go is a US telehealth provider offering compounded GLP-1 weight-loss medication with genuinely same-day telehealth visits and national shipping direct to your door. Every fact here comes from the company's own published program.

What VirtualCare2Go is

VirtualCare2Go is a US telehealth provider, offering compounded semaglutide and tirzepatide with an oral semaglutide tablet option. A live video visit is required before a prescription, and it ships nationally direct to your door, serving all 50 states.

§ VirtualCare2Go — Same-Day Visits, Higher Price

ItemDetail
TirzepatideFrom $629/mo
Video visitRequired
Oral optionSemaglutide tablet
Public state list not enumerated; cash-pay only.

What VirtualCare2Go costs

Compounded semaglutide starts from $279/month with tirzepatide from $629/month at the starting dose — on the higher side for this category.

The brand-vs-compounded question

VirtualCare2Go dispenses compounded semaglutide and tirzepatide. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

VirtualCare2Go's real strengths: same-day telehealth visits, an oral semaglutide tablet option, and national direct-to-door shipping. The trade-offs: pricing runs on the higher side for compounded semaglutide, the public state list isn't enumerated, and it's cash-pay only. As with any GLP-1 program, and especially one at this price point, compare the total cost against lower-priced alternatives before committing; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-11, and better than semaglutide head-to-head2 — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

VirtualCare2Go's same-day visits and oral option are real conveniences, but pricing runs on the higher side for this category. For a lower-cost provider with a similarly required video visit, compare it against Vitalex Health or Ondra Health. See our best tirzepatide providers ranking for the full field.

Frequently asked questions

How much does tirzepatide cost through VirtualCare2Go?

From $629/month at the starting dose.

Does VirtualCare2Go offer same-day visits?

Yes.

Is a video visit required?

Yes — a live video visit is required before a prescription.

References(2)

  1. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A, and the SURMOUNT-1 Investigators (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. PMID: 35658024. https://pubmed.ncbi.nlm.nih.gov/35658024/
  2. Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Bays HE, et al. (2025). Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5).. New England Journal of Medicine. PMID: 40353578. https://pubmed.ncbi.nlm.nih.gov/40353578/

About the author

Alan Pierce

Clinical Pharmacology Writer

About Tirzepatide Report · How we verify prices · This page last updated August 2026

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.